Romano Matthew A, Patel Himanshu J, Pagani Francis D, Prager Righard L, Deeb G Michael, Bolling Steven F
Section of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Ann Thorac Surg. 2005 May;79(5):1500-4; discussion 1500-4. doi: 10.1016/j.athoracsur.2004.08.086.
Anterior leaflet repair continues to pose significant operative challenges, particularly in patients with retracted or "short" anterior leaflets, due to rheumatic or radiation induced mitral valve disease. This often results in abandonment of repair in favor of mitral valve replacement, requiring anticoagulation and altering left ventricular (LV) function and geometry. This study examines our experience of anterior leaflet repair with patch augmentation.
Forty-two patients underwent mitral valve repair for a shortened anterior leaflet from 1994 to 2003. Twenty-two patients with a mean age of 53 +/- 6 years had radiation valvulitis (XR) whereas 20 patients, age 28 +/- 7 years had rheumatic heart disease (RHD). Those patients with XR had a mean New York Heart Association (NYHA) class of 3.2 +/- 0.4 and an angina score of 2.1 +/- 0.6 compared with a NYHA class 3.8 +/- 0.2 and no angina in RHD patients. All patients presented with severe MR. Anterior leaflet augmentation with a gluteraldehyde-treated, autologous pericardial patch and complete annuloplasty ring was used in all patients. Additionally, extensive subvalvar debridement was performed in RHD patients. Twelve XR patients underwent concomitant CABG with a mean of 2.4 +/- 0.8 grafts/patient. Additional surgical procedures included tricuspid valve repair, anterior septal defect, and aortic valve replacement. Mean follow-up was 39 +/- 10 months for XR patients and 12 +/- 25 months for RHD patients.
There were two late deaths in XR patients from underlying malignancies and no deaths in RHD patients. Two RHD patients required reoperation for recurrent mitral regurgitation at 3 and 20 months. All patients demonstrated clinical improvements (NYHA I-II) following repair. No mitral stenosis was induced.
Despite anterior leaflet shortening from XR or rheumatic alterations, opportunity still exists for gratifying mitral valve repair. By utilizing anterior leaflet patch augmentation, concomitantly with ring annuloplasty, anticoagulation is avoided, LV geometry is preserved, and follow-up reveals excellent functional improvement.
由于风湿性或放射性二尖瓣疾病,前叶修复仍然面临重大的手术挑战,尤其是对于前叶回缩或“短缩”的患者。这通常导致放弃修复而选择二尖瓣置换,这需要抗凝治疗,并改变左心室(LV)功能和形态。本研究探讨了我们使用补片增强进行前叶修复的经验。
1994年至2003年,42例患者因前叶短缩接受二尖瓣修复。22例平均年龄53±6岁的患者患有放射性心内膜炎(XR),而20例年龄28±7岁的患者患有风湿性心脏病(RHD)。XR患者的平均纽约心脏协会(NYHA)分级为3.2±0.4,心绞痛评分为2.1±0.6,而RHD患者的NYHA分级为3.8±0.2且无心绞痛。所有患者均表现为严重二尖瓣反流(MR)。所有患者均使用经戊二醛处理的自体心包补片进行前叶增强和完整的瓣环成形环。此外,RHD患者还进行了广泛的瓣下清创术。12例XR患者同时接受冠状动脉旁路移植术(CABG),平均每位患者植入2.4±0.8根移植血管。其他外科手术包括三尖瓣修复、房间隔缺损修复和主动脉瓣置换。XR患者的平均随访时间为39±10个月,RHD患者为12±25个月。
XR患者中有2例因潜在恶性肿瘤晚期死亡,RHD患者无死亡。2例RHD患者在3个月和20个月时因复发性二尖瓣反流需要再次手术。所有患者修复后临床症状均有改善(NYHA I-II级)。未诱发二尖瓣狭窄。
尽管XR或风湿性改变导致前叶短缩,但二尖瓣修复仍有令人满意的机会。通过使用前叶补片增强并同时进行瓣环成形术,可避免抗凝治疗,保留左心室形态,随访显示功能有极佳改善。